SEALBOND LTD enters DOGWOOD THERAPEUTICS, INC. with 211.38K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/17/2024ACC: 0001104659-24-109541
211.38K
Baseline shares
100% direct
211.38K
Direct ownership
1 position
21.08M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned211.38K
Total
211.38K direct211.38K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 211.38K | Direct |
| Total | 211.38K | 211.38K direct |
Derivative Holdings1
Series A Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
21.08M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
21.08M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock | — | — | 21.08M | N/A | |
| Total | 21.08M | 0.00 | ||||